Patients taking immune-suppressing therapies are at higher risk for neuroinvasive illness from ticks and mosquitoes.

Immunotherapies that target the CD20 antigen have revolutionized how patients with a variety of blood cancers and hematologic disorders have been treated. However, many patients develop resistance to ...

Cases have included chronic, neurodegenerative encephalitis that played out over months to ...

Immunotherapies that target the CD20 antigen have revolutionized how patients with a variety of blood cancers and hematologic disorders have been treated. However, many patients develop resistance to ...

National Marrow Donor Program–Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide Seven days before the first ...

Antibodies directed against the protein CD20, which is expressed by immune cells known as B cells, are used to treat B cell non-Hodgkin lymphoma and rheumatoid arthritis. Despite this, the function of ...

Therapeutic monoclonal antibodies (mAbs) are used in chronic lymphocytic leukemia immunotherapies to target the receptor CD20 at the plasma membrane of immunological B cells. Although they have been ...

For patients with primary progressive multiple sclerosis (PPMS), the time to confirmed disability progression (CDP) does not differ for those who are anti-CD20-treated and untreated, according to a ...

In summary, we performed a FACS-based genome-scale shRNA screen for coding genes in a Burkitt’s lymphoma cell line model, which identified 37 potential CD20 repressors and 51 activators, including ...

Preclinical development of tumor-infiltrating lymphocyte (TIL) based adoptive cell transfer (ACT) immunotherapy for patients with sarcoma and the potential benefit of anti-CD137 stimulation. This is ...

In a recent study posted to the medRxiv* preprint server, researchers assessed the efficacy of a third dose of coronavirus disease 2019 (COVID-19) vaccine in anti-CD20 antibody-treated individuals.